Acquired adult-onset immunodeficiency

Summary

Acquired adult-onset immunodeficiency (MONDO:0017617) is a disease and 1 clinical trial. A subtype of acquired immunodeficiency — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: Unknown (Worldwide)
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	acquired adult-onset immunodeficiency
Mondo ID	MONDO:0017617
Orphanet	306431
UMLS	C5191336
MedGen	1684214
GARD	0011992
Is cancer (heuristic)	no

Also known as: acquired immunodeficiency of adults · adult acquired immunodeficiency · adult onset immunodeficiency syndrome · adult-onset immunodeficiency due to anti-interferon-gamma autoantibody · adult-onset immunodeficiency with acquired Anti-interferon-gamma autoantibodies · adult-onset immunodeficiency with anti-interferon-gamma autoantibodies · anti-IFN-gamma autoantibody syndrome

Disease family

Classification path: disease › human disease › disease by body system or component › immune system disorder › acquired immunodeficiency › acquired adult-onset immunodeficiency

Related subtypes (1): Good syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05354583	Not specified	COMPLETED	Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome